Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trial for the treatment of warm autoimmune hemolytic anemia; phase III clinical trial for the treatment of hospitalized COVID-19 patients; and phase III clinical trial for the treatment of COVID-19. In addition, the company is developing R289, an oral interleukin receptor associated kinase 1/4 inhibitor, which is in phase I clinical trial for autoimmune, inflammatory, and hematology-oncology diseases; and R552, a receptor-interacting serine/threonine-protein kinase 1 inhibitor that has completed phase I clinical trial for autoimmune and inflammatory diseases. It has research and license agreements with AstraZeneca AB for the development and commercialization of R256, an inhaled JAK inhibitor; BerGenBio AS for the development and commercialization of AXL inhibitors in oncology; and Daiichi Sankyo to develop murine double minute 2 inhibitors for solid and hematological malignancies, as well as license and supply agreement with Kissei Pharmaceutical Co., Ltd. to develop and commercialize Fostamatinib. The company also has a license agreement and strategic collaboration with Eli Lilly and Company to co-develop and commercialize R552 for various indications, including autoimmune and inflammatory diseases, as well as other non-central nervous system (non-CNS) disease development candidates. Rigel Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in South San Francisco, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Rigel Pharmaceuticals Inc..
Rigel Pharmaceuticals Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Rigel Pharmaceuticals Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Rigel Pharmaceuticals Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Rigel Pharmaceuticals Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Rigel Pharmaceuticals Inc. and all latest updates of the company are provided.
The 2025 version of Rigel Pharmaceuticals Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Rigel Pharmaceuticals Inc.- Key Facts
2.2 Rigel Pharmaceuticals Inc.- Geographic Locations
2.3 Rigel Pharmaceuticals Inc.- Subsidiaries and Affiliates
2.4 Rigel Pharmaceuticals Inc.- Business Divisions
2.5 Rigel Pharmaceuticals Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Rigel Pharmaceuticals Inc. Strategic Analysis Review
3.1 Rigel Pharmaceuticals Inc.- Key Strategies
3.2 Rigel Pharmaceuticals Inc.- Company Outlook Statement
3.3 Rigel Pharmaceuticals Inc.- SWOT Analysis
3.3.1 Rigel Pharmaceuticals Inc.- Key Strengths
3.3.2 Rigel Pharmaceuticals Inc.- Key Weaknesses
3.3.3 Rigel Pharmaceuticals Inc.- Potential Opportunities
3.3.4 Rigel Pharmaceuticals Inc.- Potential Threats
3.4 Rigel Pharmaceuticals Inc.- Key Competitors
4. Business Description of the Company
4.1 Rigel Pharmaceuticals Inc.- Business Overview
4.2 Rigel Pharmaceuticals Inc.- Operations by Segment
5 Products and Services Details
5.1 Rigel Pharmaceuticals Inc.- Key Products
5.2 Rigel Pharmaceuticals Inc.- Key Service Areas
5.3 Rigel Pharmaceuticals Inc.- Key Brands
6 Company Developments
6.1 Rigel Pharmaceuticals Inc.- Company History
6.2 Rigel Pharmaceuticals Inc.- Latest Developments
7 Financial Analysis
7.1 Rigel Pharmaceuticals Inc.- Income Statements
7.2 Rigel Pharmaceuticals Inc.- Balance Sheet
7.3 Rigel Pharmaceuticals Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Rigel Pharmaceuticals Inc.- Direct Competitors
8.2 Rigel Pharmaceuticals Inc.- Competitor Financial Ratios comparison
8.3 Rigel Pharmaceuticals Inc.- Competitor Stock Charts Comparison
8.4 Rigel Pharmaceuticals Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
